Peter Mézeš
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
- Inflammatory mediators and NSAID effects
Papers in
-
- Antibiotic Resistance in Bacteria 7
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- C L LaneJ. O. LampenRose Z. TerwilligerMichihiro TakahashiRonald S. DumanMarco ContiJames T. DownsIvan G. Otterness
- Journals
- Journal of Bacteriology (2 papers)FEBS Letters (2 papers)Journal of Biological Chemistry (2 papers)Matrix Biology (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesCanadaSlovakia
In The Last Decade
Peter Mézeš
16 papers receiving 448 citations
Peers
Comparison fields: 5 of 79
- Molecular Medicine 82
- Pharmacology 125
- Rheumatology 88
- Immunology and Allergy 33
- Biological Psychiatry 13
Countries citing papers authored by Peter Mézeš
This map shows the geographic impact of Peter Mézeš's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mézeš with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mézeš more than expected).
Fields of papers citing papers by Peter Mézeš
This network shows the impact of papers produced by Peter Mézeš. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mézeš. The network helps show where Peter Mézeš may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Mézeš, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 27 | |
| 2 | 2001 | 74 | |
| 3 | 1999 | 51 | |
| 4 | 1999 | 8 | |
| 5 | 1999 | 146 | |
| 6 | 1996 | 6 | |
| 7 | 1993 | 11 | |
| 8 | 1985 | 20 | |
| 9 | 1985 | 27 | |
| 10 | 1983 | 23 | |
| 11 | 1983 | 29 | |
| 12 | 1983 | 9 | |
| 13 | 1983 | 14 | |
| 14 | 1982 | 7 | |
| 15 | 1982 | 6 | |
| 16 | 1982 | 17 |
About Peter Mézeš
Peter Mézeš is a scholar working on Molecular Medicine, Pharmacology, Immunology and Allergy, Rehabilitation and Molecular Biology, having authored 16 papers that have together received 475 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Bacterial Genetics and Biotechnology (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Inorganic and Organometallic Chemistry (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Enzyme Catalysis and Immobilization (2 papers), Bacterial biofilms and quorum sensing (2 papers) and Enzyme Structure and Function (2 papers). The work is most often cited by research in Molecular Medicine (82 citations), Pharmacology (125 citations), Rheumatology (88 citations), Immunology and Allergy (33 citations) and Biological Psychiatry (13 citations). Peter Mézeš has collaborated with scholars based in United States, Canada and Slovakia. Frequent co-authors include C L Lane, J. O. Lampen, Rose Z. Terwilliger, Michihiro Takahashi, Ronald S. Duman, Marco Conti, James T. Downs, Ivan G. Otterness, Yue Yang and Gary I. Dmitrienko. Their work appears in journals such as Journal of Bacteriology, FEBS Letters, Journal of Biological Chemistry, Matrix Biology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.